Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.

about

Identiﬁcation of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.

P2860

Q47109892-810213AD-6D34-4AF5-A1B8-2EF21841ED59

P2860

Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.

Item

http://www.wikidata.org/entity/Q38892486

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Targeting pathways mediating r ...... arcinoma of the head and neck.

@en

type

Item

label

Targeting pathways mediating r ...... arcinoma of the head and neck.

@en

prefLabel

Targeting pathways mediating r ...... arcinoma of the head and neck.

@en

P1476

Targeting pathways mediating r ...... arcinoma of the head and neck.

@en

P2093

Arif Y Shaikh

http://www.w3.org/2001/XMLSchema#string

Bruce E Brockstein

http://www.w3.org/2001/XMLSchema#string

Mihir K Bhayani

http://www.w3.org/2001/XMLSchema#string

Nicholas P Campbell

http://www.w3.org/2001/XMLSchema#string

Thomas A Hensing

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Therapeutic insights from genomic studies of head and neck squamous cell carcinomas

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker

Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

P304

847-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2016.1202116

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27400139

http://www.w3.org/2001/XMLSchema#string

Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.

about

P2860

P2860

Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698